Clinical Outcomes of COVID-19 Cases and Influencing Factors of Severe Cases in Qingdao City: A Retrospective Cohort Study

Jing Jia, Dai Xiao-qi, Xiaolin Jiang, Shuo Li, Xia Wang, Ruqin Gao, Fachun Jiang, Fei Qi, Dianmin KangResearch 2020 · DOI

Introduction

During the initial wave of the COVID-19 pandemic, understanding the clinical trajectory of the virus was paramount for effective healthcare management. While early data from Wuhan provided a foundational understanding, regional variations in demographics and healthcare infrastructure necessitated localized studies. This retrospective cohort study examines 81 confirmed cases in Qingdao, China, to identify the clinical outcomes and specific factors that influence the progression to severe illness.

Methods

The study analyzed data from 81 patients confirmed to have COVID-19 in Qingdao City between January and May 2020. Researchers utilized the National Notifiable Disease Surveillance System to gather demographic, epidemiological, and clinical data.

Patients were classified into four categories: mild, ordinary, severe, and critical. For statistical analysis, the "severe" cohort included severe, critical, and fatal cases, while "non-severe" included mild and ordinary cases. The team employed Pearson’s chi-square tests for univariate analysis and Multivariate Logistic Regression to identify independent risk factors. A General Linear Model (GLM) was also used for sensitivity analysis to ensure the robustness of the findings.

Clinical Trajectory and Outcomes

The study revealed a distinct timeline for disease progression. The median time from the onset of symptoms to hospital admission was 3.67 days. For those who progressed to a severe state, the median time to reach that stage was 6.00 days after the initial onset of symptoms. This identifies a critical one-week window for medical intervention.

The overall fatality rate in the Qingdao cohort was 1.23%, significantly lower than rates observed in other regions during the same period. The median length of hospitalization was 15.63 days, with a total median illness duration of 21.00 days. By the 30-day mark, 85% of mild cases had recovered, compared to 64% of severe cases.

Key Risk Factors: The "CT Paradox"

Two primary factors were identified as significant predictors of severe disease progression:

  1. Age: Patients over the age of 40 were nearly six times more likely to develop severe illness (Odds Ratio = 5.797).
  2. Initial Chest CT Results: In a counterintuitive finding, a normal initial chest CT scan was associated with a higher risk of progressing to severe illness. The study found that an abnormal initial scan had an Odds Ratio of 0.1140, suggesting it was statistically "protective."

The researchers hypothesize that this "CT Paradox" is likely due to clinical behavior rather than biological factors. Patients presenting with abnormal lung scans were often prioritized for aggressive, early treatment. Conversely, those with normal initial scans might have been monitored less intensely, leading to delayed intervention as their condition worsened.

Discussion and Conclusion

The findings underscore the importance of the "Four Early" strategy: early detection, isolation, diagnosis, and treatment. The relatively low fatality rate in Qingdao suggests that these measures, combined with localized data to guide resource allocation, were effective.

However, the study has limitations. The sample size of 81 cases is relatively small, which may limit the statistical power of the multivariate analysis. Additionally, the data reflects the ancestral strain of SARS-CoV-2; subsequent variants like Delta and Omicron may exhibit different progression profiles.

In conclusion, clinicians should remain vigilant even when initial diagnostic imaging appears normal, particularly in patients over 40. Identifying the 6-day window for severe progression allows for more targeted monitoring and the rational allocation of medical resources during an epidemic.

Summary updated

Abstract

Abstract BackgroundTo analyze the clinical outcomes of COVID-2019 cases and the influencing factors of severe cases in Qingdao City and provide theoretical reference basis for optimizing medical treatment and the strategies of epidemic prevention and control. MethodsThe demographical, epidemiological, clinical data of 81 confirmed COVID-2019 cases in Qingdao City were collected via epidemiological investigation and clinical process tracking. The status of cure, discharge, clinical outcome and influencing factors were analyzed in our study. ResultsAmong the 81 cases,12(14.81%) and 55(67.90%) were mild and ordinary, 9(11.11%) and 4(4.94%) were severe and critical, and 1 critical cases (1.23%) developed into fatal, with the fatality rate 1.23%. The median time from onset of symptoms to hospital admission were 3.67 days (IQR, 1.75 to 6.71). The median duration of illness were 21.00 days (IQR, 16.00 to 26.00) and the median length of hospitalization were 15.63 days (IQR, 11.60 to 20.50). The median time for progression to severe cases was 6.00 days after onset (IQR, 5.00-10.00). The median duration of severe cases was 8.00 days (IQR, 6.25-14.00). Age older than 40 years old (OR=5.797, 95% CI : 1.064~31.568) and first chest CT abnormal (OR=0.1140, 95% CI : 0.014~0.923) were the influencing factors of COVID-2019 severe cases. ConclusionsOlder age and first chest CT normal would be more prone to develop to severe cases of COVID-2019. During the epidemic period, it was necessary to classify and manage cases according to the needs of prevention and control in order to ensure the rational allocation of medical resources.
BibTeX
@inproceedings{jia2020clinical,
  author = {Jing Jia and Dai Xiao-qi and Xiaolin Jiang and Shuo Li and Xia Wang and Ruqin Gao and Fachun Jiang and Fei Qi and Dianmin Kang},
  title = {{Clinical Outcomes of COVID-19 Cases and Influencing Factors of Severe Cases in Qingdao City: A Retrospective Cohort Study}},
  booktitle = {Research},
  year = {2020},
  doi = {10.21203/rs.3.rs-95094/v1},
}
Figure